Clinical Trials Directory

Trials / Completed

CompletedNCT03842293

Clinical Evaluation of PROMIS in CKD

Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
213 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
8 Years – 21 Years
Healthy volunteers

Summary

The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.

Detailed description

The National Institutes of Health (NIH)-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) network has developed over 20 pediatric instruments, both child-report and parent-proxy editions. Cross-sectional evaluations of the validity of the instruments have established that they are ready for integration into clinical research and practice. The next step in their ongoing evaluation is to assess their prospective clinical validity in a variety of health conditions. This study addresses the clinical evaluation of the measures in children with chronic kidney disease (CKD). Through baseline surveys and six follow-up surveys over a two-year period, Investigators are collecting self-report (child) and parent-proxy report of 11 pediatric PROMIS measures. Each of these PROMIS measures is described in the Main Outcome Measures section. Investigators are also collecting assessments of disease activity from clinical data. The selection of self-report and parent proxy patient-reported outcome (PRO) measures were determined through qualitative content validation. The analytic goal of this project is to evaluate baseline (cross-sectional) and longitudinal associations between PROMIS pediatric outcome measures and changes in the clinical status of patients with CKD. Our primary hypothesis is that as kidney function declines, self-reported health will worsen.

Conditions

Timeline

Start date
2017-06-22
Primary completion
2020-08-30
Completion
2020-08-30
First posted
2019-02-15
Last updated
2020-11-27

Locations

16 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT03842293. Inclusion in this directory is not an endorsement.